MedPath

Japan Obesity & Metabolic Syndrome Study (JOMS) supported by Clinical Study of Network for Endocrine and metabolic Diseases, Policy-Based Medical Service of National Hospital Organization.

Not Applicable
Conditions
Obesity
Registration Number
JPRN-UMIN000000559
Lead Sponsor
Japan Obesity and Metabolic Syndrome Study (JOMS) Network Group, Endocrine and Metabolic Diseases Division, National Hospital Organization, supported by Ministry of Health, Labour and Welfare of Japan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
500
Inclusion Criteria

Not provided

Exclusion Criteria

Severe Liver Dysfunction and Liver cirrhosis Severe Renal Dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The success rate of weight reduction. Detection of the influencing factors in the success rate.
Secondary Outcome Measures
NameTimeMethod
The rate and its characteristic of the Metabolic Syndrome in Japanese Obese patients adn its cheracteristic. The effects ofweight reduction in preventing the progression of arteriosclerosis (Pulse Wave Velocity: PWV & CAVI) and the onset of cardiovascular disease.
© Copyright 2025. All Rights Reserved by MedPath